1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Advanced NSCLC: new trials by email Literature Review of Advanced NSCLC trials Research Report on Advanced NSCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations CT053PTSA - Advanced NSCLC | Phase 2 | Withdrawn | Sunshine Lake Pharma Co., Ltd. | 2022-11-27 | 2026-05-14 |
Sunshine Lake Pharma Co., Ltd. (1)
Li Zhang, MD (1)